Omeros Corp. (OMER)
10.90
-1.18
(-9.77%)
USD |
NASDAQ |
Apr 02, 16:00
10.92
+0.02
(+0.18%)
After-Hours: 20:00
Omeros EPS Diluted (Quarterly) : 0.9771 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.4493 |
| REGENXBIO, Inc. | -1.298 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 79.89M |
| Total Expenses (Quarterly) | -79.89M |
| Enterprise Value | 1.008B |
| Earnings Yield | -5.09% |
| Normalized Earnings Yield | 4.807 |